Rx (Prescription Medicine)
USD $ 122.00
卡非佐米 60毫克注射液是一种处方药，用于治疗某些类型的癌症，例如多发性骨髓瘤。它通过靶向和破坏癌细胞发挥作用。该药物由医疗专业人员静脉给药。
卡非佐米 60毫克注射液是一种靶向治疗药物，用于治疗某些类型的癌症。其活性成分卡非佐米是一种蛋白酶体抑制剂，通过阻断蛋白酶体的作用而发挥作用。蛋白酶体负责分解细胞内不需要或受损的蛋白质。通过抑制蛋白酶体，卡非佐米可以导致癌细胞死亡，尤其是多发性骨髓瘤细胞，这些细胞的存活通常依赖于蛋白酶体活性。该注射剂应在合格医疗专业人员的监督下静脉给药。在开始治疗前，务必告知医生您的完整病史，包括任何肾脏或肝脏问题、心脏疾病或肺部疾病。患者可能会出现副作用，定期监测至关重要。请按照您的医疗保健提供者的指示储存此药物，通常在室温下并避光保存。
| Brand Name | |
|---|---|
| Molecule | |
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type |
其他品牌的 Carfilzomib 60 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
